Navigation Links
Maryland Stem Cell Research Commission Funds 36 New Projects in FY 2011

COLUMBIA, Md., May 25, 2011 /PRNewswire/ -- The Maryland Stem Cell Research Commission (Commission) has completed its review of the 180 applications received in response to its three FY 2011 Requests for Applications (RFAs). The board of directors of the Maryland Technology Development Corporation (TEDCO) approved the Commission's recommendation to fund 36 new projects with the Maryland Stem Cell Research Fund's (MSCRF) $10.4 million FY 2011 budget.

As highlighted in its 2011 RFAs, the Commission gave preference to proposals that focus on advancing regenerative medicine, by selecting promising research that addresses osteoporosis, traumatic brain injuries, heart disease, cancer, diabetes, schizophrenia, ALS, autism, DNA damage, intestinal tissue generation, clinical drug screenings, and other debilitating and costly medical conditions. This funding cycle, the Commission also encouraged collaborations, resulting in 10 awardees (more than 25 percent) proposing to work with private biotech companies. In a groundbreaking new pilot program, two MSCRF-funded researchers will collaborate with scientists funded by the California Institute of Regenerative Medicine (CIRM). These two projects, studying red blood cell production and traumatic axonal injuries, will leverage Maryland's investment in stem cell research with more than $7 million in CIRM funding.

"Each year, Maryland's stem cell research program is a national leader in research and innovation while creating jobs and stimulating our State economy," said Governor Martin O'Malley. "I'd like to congratulate this year's awardees, and we look forward to their contributions to the field."

This year's MSCRF awards include:

  • 9 Investigator-Initiated Research Grants (RFA-MD-11-01) - providing up to $200,000 of direct costs per year, for up to three years, to investigators with preliminary data to support their hypotheses;

  • 13 Exploratory Research Grants (RFA-MD-11-02) - providing up to $100,000 of direct costs per year, for up to two years, to new stem cell researchers (young investigators and scientists from other fields), for new approaches, mechanisms or models that may differ from current thinking in the field and/or new hypotheses that have little or no preliminary data; and

  • 14 Post-Doctoral Fellowship Research Grants (RFA-MD-11-03) - providing up to $55,000 per year, for up to two years, including direct and indirect costs and fringe benefits, to post-doctoral fellows.  

All MSCRF-funded research must be conducted in Maryland, and must involve human stem cells.

For a complete list of the names of the Principal Investigators (PIs), their project titles and institutions, please visit the awardees section of the website (

Each grant awarded by the Commission is contingent upon the PI obtaining all applicable ethical approvals to conduct the specified research, as well as a signed agreement with TEDCO that describes the scope of the project, requirements for sharing any cell line(s) developed with MSCRF funding and a commitment to publish results.

"We are pleased to announce the MSCRF grant awards for FY 2011," said Margaret Conn Himelfarb, MPH, chair of the Commission. "These projects exemplify Maryland's investment in world-class, cutting-edge research. We are delighted that our collaboration with the California Institute of Regenerative Medicine will significantly augment State funding, establish new teams of expert investigators and expedite advances in regenerative medicine. The Commission is grateful to Governor O'Malley and our legislators for their visionary leadership and ongoing support of stem cell research. This pioneering science will continue to return dividends to our State."

The final amount of each award will be determined during the due diligence process and will be listed in the MSCRF annual report scheduled for release in December 2012. All currently funded MSCRF researchers are required to present their findings at the 4th Annual Maryland Stem Cell Research Symposium to be held on October 6, 2011 at Towson University.  

About the Maryland Stem Cell Research Commission

The Maryland Stem Cell Research Fund (MSCRF) was established by the State of Maryland under the Maryland Stem Cell Research Act of 2006 to promote State-funded stem cell research and cures through grants and loans to public and private entities in the State. Administered by The Maryland Technology Development Corporation (TEDCO), the MSCRF is overseen by an independent Commission that sets policy and develops criteria, standards and requirements for applications to the Fund. The current MSCRF budget for FY2012 is $12.4 million. For more information about the Maryland Stem Cell Research Fund and a list of Commission members, please visit

Media Contact:

Kathleen Shaffer

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at

SOURCE Maryland Stem Cell Research Commission
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Novavax Named Biotechnology Firm of the Year by Tech Council of Maryland
2. Mtech Announces Winners of the 2011 University of Maryland $75K Business Plan Competition
3. University of Maryland School of Medicine publishes scientific paper on 2001 anthrax attacks
4. The University of Maryland Baltimore (UMB) and Paragon Bioservices, Inc. Announce the Formation of a Public-Private Stem Cell Technology Consortium
5. Mtech Announces Semifinalists for University of Maryland $75K Business Plan Competition
6. University of Maryland School of Medicine publishes scientific paper on 2001 anthrax attacks
7. Maryland Governor Martin OMalley to Visit Novavax in Celebration of HHS-BARDA Contract Award
8. Biophysical Society to Hold 55th Annual Meeting in Baltimore, Maryland, March 5-9, 2011
9. CSL Behring Awards Advocacy Grants to Patient Groups in Maryland, New England, the Midwest and Washington
10. Maryland Stem Cell Research Commission to Host Third Annual Maryland Stem Cell Research Symposium
11. Governor OMalley Announces State Grants Available For Maryland Bio Companies
Post Your Comments:
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a company ... to the medical community, has closed its Series A ... Nunez . "We have received a commitment ... capital we need to meet our current goals," stated ... us the runway to complete validation on the current ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest features ... will also be presenting a scientific poster on Disrupting Clinical Trials in The ...
(Date:6/23/2016)... FRANCISCO , June 22, 2016  Amgen (NASDAQ: ... sponsorship of the QB3@953 life sciences incubator ... human health. The shared laboratory space at QB3@953 was ... overcome a key obstacle for many early stage organizations ... part of the sponsorship, Amgen launched two "Amgen Golden ...
Breaking Biology Technology:
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: ) ... provide their customers enhanced security to access and ...
(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
Breaking Biology News(10 mins):